Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kringle structures and antiangiogenesis.

Yihai Cao1, Renhai Cao, Niina Veitonmäki

  • 1Microbiology and Tumor Biology Center, Karolinska Institute, S-171 77 Stockholm, Sweden. yihai.cao@mtc.ki.se

Current Medicinal Chemistry. Anti-Cancer Agents
|April 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and Fibrosis.

Investigative ophthalmology & visual science·2026
Same author

Mechanisms of Pericyte-Mediated Cancer Metastasis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancer.

Theranostics·2026
Same author

Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 Diabetes.

Antioxidants (Basel, Switzerland)·2026
Same author

MTFR1L is a cardiac antiaging factor for maintenance of mitochondrial homeostasis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Selenium derivatives as cancer preventive agents.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Lycopene: a review of its potential as an anticancer agent.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Sulfo-quinovosyl-acyl-glycerol (SQAG), a eukaryotic DNA polymerase inhibitor and anti-cancer agent.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Current drug therapy for prostate cancer: an overview.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Lanthanides as anticancer agents.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy.

Current medicinal chemistry. Anti-cancer agents·2005
See all related articles

Kringle domains, found in proteins like angiostatin, are crucial for inhibiting tumor angiogenesis. Proteolytic processing reveals these cryptic fragments, offering a new strategy for developing anti-cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The adult vascular system maintains quiescence through a balance of pro-angiogenic and anti-angiogenic factors.
  • Tumors disrupt this balance, producing specific inhibitors like angiostatin to promote their growth.
  • Angiostatin, a tumor-derived angiogenesis inhibitor, is under investigation for cancer therapy due to its potent anti-tumor effects.

Purpose of the Study:

  • To review the structural and functional relationships of kringle domains in regulating angiogenesis and tumor growth.
  • To explore the potential of kringle domains as a basis for identifying novel angiogenesis inhibitors.
  • To highlight the role of proteolytic processing in uncovering anti-angiogenic activity.

Main Methods:

  • Review of existing literature on angiostatin, kringle domains, and angiogenesis.

Related Experiment Videos

  • Analysis of structural features of kringle domains and their correlation with anti-angiogenic activity.
  • Examination of the mechanism of proteolytic processing in releasing active kringle fragments.

    • Main Results:

    • Angiostatin, composed of kringle domains from plasminogen, effectively inhibits tumor angiogenesis and growth.
    • Disulfide bond-linked kringle architectures are essential for angiostatin's anti-angiogenic activity.
    • Kringle fragments from various proteins also exhibit anti-angiogenic properties, often requiring cleavage from parental proteins.

    Conclusions:

    • Kringle domains represent a conserved structural motif with specific anti-angiogenic activity.
    • Proteolytic processing is critical for revealing the anti-angiogenic potential of these "cryptic" kringle fragments.
    • Kringle domains offer a promising structural framework for the development of new anti-cancer therapeutics targeting angiogenesis.